White T K, Schnaar R L
Department of Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Biochim Biophys Acta. 1994 Dec 30;1196(2):218-26. doi: 10.1016/0005-2736(94)00242-8.
An anionic glycolipid and phospholipid binding protein was characterized in detergent-solubilized rat brain synaptosomes using a synthetic, polyvalent radiolabeled ganglioside-protein conjugate as radioligand. Gangliosides are prominent cell surface glycoconjugates in vertebrate brain, where they may function in membrane protein regulation or in cell-cell recognition. The neoganglioprotein (GT1b)13BSA was radioiodinated and used to probe solubilized synaptosomal proteins for ganglioside binding activity using a receptor-ligand precipitation assay. Binding data revealed a high affinity (KD = 1 nM), saturable (Bmax = 173 pmol/mg protein) binding activity that was proteinase sensitive, calcium independent and maximal at neutral pH. Size exclusion chromatography of the synaptosomal (GT1b)13BSA binding activity indicated a M(r) of approximately 28 kDa. Binding activity with similar characteristics was solubilized from other rat tissues, with activity from sciatic nerve = muscle > synaptosomes > central nervous system myelin = liver. Gangliosides added as mixed detergent-lipid micelles inhibited (GT1b)13BSA binding: GT1b, GD1a and GD1b were the most effective inhibitors (IC50 approximately 200 nM), while GM1 and GM3 were 5-fold less effective. In addition, the sphingolipids sulfatide and sialylneolactotetraosylceramide were effective inhibitors, with IC50 values of 300 nM and 200 nM, respectively. The neutral sphingolipid GA1 did not block (GT1b)13BSA binding. Phosphatidylcholine and phosphatidylethanolamine were non-inhibitory, however phosphatidylglycerol, phosphatidylserine, and phosphatidylinositol inhibited half-maximally at 200-300 nM. Inhibition by both gangliosides and anionic phospholipids was competitive with (GT1b)13BSA. We conclude that a binding protein for anionic glycolipids and phospholipids is distributed on nerve and muscle membranes.
利用合成的多价放射性标记神经节苷脂 - 蛋白质共轭物作为放射性配体,对去污剂溶解的大鼠脑突触体中的一种阴离子糖脂和磷脂结合蛋白进行了表征。神经节苷脂是脊椎动物脑中突出的细胞表面糖缀合物,它们可能在膜蛋白调节或细胞间识别中发挥作用。新神经节蛋白(GT1b)13BSA 经放射性碘化后,使用受体 - 配体沉淀测定法来探测溶解的突触体蛋白的神经节苷脂结合活性。结合数据显示出高亲和力(KD = 1 nM)、可饱和(Bmax = 173 pmol/mg 蛋白)的结合活性,该活性对蛋白酶敏感、不依赖钙且在中性 pH 下最大。对突触体(GT1b)13BSA 结合活性进行的尺寸排阻色谱表明其分子量约为 28 kDa。从其他大鼠组织中也溶解出了具有相似特征的结合活性,坐骨神经 = 肌肉 > 突触体 > 中枢神经系统髓磷脂 = 肝脏的活性依次递减。作为混合去污剂 - 脂质微团添加的神经节苷脂会抑制(GT1b)13BSA 结合:GT1b、GD1a 和 GD1b 是最有效的抑制剂(IC50 约为 200 nM),而 GM1 和 GM3 的抑制效果则低 5 倍。此外,鞘脂类的硫苷脂和唾液酸新乳糖四糖神经酰胺也是有效的抑制剂,IC50 值分别为 300 nM 和 200 nM。中性鞘脂 GA1 不会阻断(GT1b)13BSA 结合。磷脂酰胆碱和磷脂酰乙醇胺无抑制作用,然而磷脂酰甘油、磷脂酰丝氨酸和磷脂酰肌醇在 200 - 300 nM 时能半数抑制。神经节苷脂和阴离子磷脂的抑制作用均与(GT1b)13BSA 存在竞争性。我们得出结论,阴离子糖脂和磷脂的结合蛋白分布在神经和肌肉膜上。